Emotional problems and dysregulation in children/youth with ADHD: predictive and moderating effects in a randomized controlled trial of methylphenidate and neurofeedback.

In 30 seconds

This randomized controlled trial examined emotional problems and dysregulation in 146 children aged 7–13 years with inattentive or combined-type ADHD, comparing methylphenidate (MPH) with home neurofeedback (NF). Internalizing emotional problems improved across intervention groups, with no between-group difference; analyses supported NF’s non-inferiority to MPH for this outcome. Emotional dysregulation also improved in all groups, but effects were significantly more pronounced with MPH. Models using emotional difficulties and executive-function measures had limited ability to predict treatment outcomes, so the findings do not establish a basis for personalized treatment selection.

Key findings

• Internalizing emotional problems improved across groups, with no between-intervention effect; non-inferiority analyses supported NF versus MPH.
• Parent-rated internalizing-problem effect sizes were NF SMR d = -0.396, NF TBR d = -0.367, and MPH d = -0.409.
• Emotional dysregulation improved with all interventions, but effects were significantly more pronounced with MPH.
• Prediction models showed limited value for forecasting treatment outcomes.

Why it matters

Emotional difficulties commonly accompany ADHD, yet treatment comparisons often focus on core ADHD symptoms. These results suggest that both methylphenidate and home neurofeedback may be associated with improvement in internalizing emotional problems, while methylphenidate showed a stronger effect on dysregulation. The limited predictive value of the assessed emotional and executive-function measures cautions against using them to select between these treatments on the basis of this study.

What to keep in mind

The per-protocol sample was modest, and the NF TBR subgroup was small (n = 15). The authors state that further studies are needed to confirm and extend the findings.